Corpus Comparables
655 deals · 365 realized
🛡️ Public data only — no PHI permitted on this instance.
Corpus Size
655
total deals
Realized Deals
365
with MOIC data
Comparables Found
20
most recent realized deals
Sectors Covered
98
in corpus
REALIZED CORPUS DEALSmost recent realized exits · 20 shown
Comparable Transactions
| Deal | Sector | Year | EV | EV/EBITDA | MOIC | IRR | Hold | Payer Mix |
|---|---|---|---|---|---|---|---|---|
| BrightSpring Health Services – KKR IPO | — | 2024 | 4.8B | 15.0× | 2.10× | 16.0% | 5.0yr | — |
| ResCare / BrightSpring Health Services | — | 2024 | 2.8B | 10.8× | 1.40× | 6.0% | 6.0yr | 15%C |
| Prospect Medical Holdings – CA Hospita | — | 2023 | 150M | — | 0.10× | -25.0% | 8.0yr | 15%C |
| Alignment Healthcare – TPG Secondary B | — | 2023 | 900M | — | 0.60× | -9.0% | 5.0yr | 5%C |
| Signify Health – CVS Health / Aetna Ac | — | 2023 | 8.0B | 44.4× | 4.50× | 46.0% | 4.0yr | 7%C |
| One Medical (1Life Healthcare) – Amazo | — | 2023 | 3.9B | — | 1.50× | 15.0% | 3.0yr | 85%C |
| Parsley Health / Deutsche Telekom (T-H | — | 2023 | 200M | — | 1.80× | 22.0% | 3.0yr | 55%C |
| Envision Healthcare / KKR bankruptcy e | emergency_medicine | 2023 | 1.0B | — | 0.10× | -30.0% | 6.0yr | 38%C |
| Invitae / GeneDx Merger | — | 2022 | 150M | — | 0.10× | -70.0% | 2.0yr | 58%C |
| Calibrate Health / AXA Venture Partner | — | 2022 | 200M | — | 0.40× | -24.0% | 3.0yr | 60%C |
| American Renal Associates — Centerbrid | dialysis | 2022 | 775M | 10.3× | 2.00× | 26.0% | 3.0yr | 24%C |
| TeamHealth — Blackstone Exit via Spons | physician_group | 2022 | 5.5B | 13.1× | 1.20× | 3.0% | 7.0yr | 47%C |
| OrthoSouth – Alaris Capital Partners | Orthopedics | 2022 | 180M | 10.0× | 2.80× | 38.0% | 3.0yr | 68%C |
| Agilon Health – Advent International / | — | 2021 | 5.5B | — | 4.20× | 38.0% | 5.0yr | — |
| Covenant Physician Partners – USPI / T | — | 2021 | 1.4B | 11.7× | 4.50× | 27.0% | 6.0yr | — |
| Alignment Healthcare – IPO / Warburg P | — | 2021 | 4.2B | — | 3.80× | 30.0% | 5.0yr | — |
| Acadia Healthcare – Behavioral Portfol | — | 2021 | 680M | 9.4× | 2.10× | 19.0% | 4.0yr | 24%C |
| Privia Health Group – IPO / Goldman Sa | — | 2021 | 3.2B | 114.3× | 1.80× | 22.0% | 4.5yr | 46%C |
| Agilon Health – IPO / Clayton Dubilier | — | 2021 | 5.8B | — | 0.70× | -14.0% | 3.0yr | 3%C |
| Cano Health – SPAC / Jaws Acquisition | — | 2021 | 4.4B | — | 0.05× | -70.0% | 2.5yr | 8%C |